B
Bull
Bull · 25%ELV
$456.04
Scenario price
$394.430
-4.615 (-1.17%)At close
Loading chart…
- High
- 403.155
- Open
- 400.810
- VWAP
- 397.33
- Vol
- 561.39K
- Mkt Cap
- 124.52B
- Low
- 394.400
- Amount
- 223.06M
- EV/EBITDA, TTM
- 10.08
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
AI analysis of Elevance Health Inc (ELV)
holdElevance Health Inc is currently a hold. The stock is priced at $394.43, with a forward P/E ratio of 14.86, suggesting it is relatively undervalued compared to its earnings potential. However, the RSI is at 42.06, indicating it is nearing oversold territory, which could lead to a price rebound. The main risk is the recent insider selling trend, which has increased by 135.25% over the last quarter, suggesting potential concerns among hedge funds.
Valuation Metrics
The current forward P/E ratio for Elevance Health Inc (ELV) is 14.86, compared to its 5-year average forward P/E of 13.76.
Alphio AI Price Scenarios for ELV
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding ELV
Events Timeline
News
6.508-14CNBCBaupost Group Increases Stakes in Alphabet and Amazon
8.508-07GlobenewswireElevra Completes Transaction with Wildcat Resources
2.008-05NASDAQ.COMImportance of Market Capitalization Analysis
7.507-30NewsfilterElevance Health Enhances Cancer Care Experience
8.507-28GlobenewswireElevra Lithium Reports Strong Performance and Strategic Financing Package
ELV FAQ — answered by Alphio AI
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Elevance Health Inc is currently a hold. The stock is priced at $394.43, with a forward P/E ratio of 14.86, suggesting it is relatively undervalued compared to its earnings potential. However, the RSI is at 42.06, indicating it is nearing oversold territory, which could lead to a price rebound. The main risk is the recent insider selling trend, which has increased by 135.25% over the last quarter, suggesting potential concerns among hedge funds.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。